EPISODE BREAKDOWN
Mental Health Risks After Chronic Illness Diagnosis (00:00:27) Study shows depression risk spikes after chronic condition diagnosis, especially in first month and among older adults.
Vaginal Estradiol Safety in Women with Prior Stroke (00:01:06) Case-control study finds vaginal estradiol does not increase recurrent ischemic stroke risk in postmenopausal women.
Approval of Generic Liraglutide for Obesity (00:01:36) First generic liraglutide approved in US, expanding access to GLP-1 therapy for weight management in adults and adolescents.
GLP-1 Receptor Agonists and Cancer Risk (00:02:15) Large cohort study links GLP-1 use to lower overall cancer risk, especially endometrial and ovarian, but notes possible kidney cancer trend.
Semaglutide vs Tirzepatide for Cardiovascular Outcomes (00:03:01) Real-world data: semaglutide users with obesity and CVD have lower major cardiovascular event risk than tirzepatide users.
Editor's note: Episode timestamps produced using AI tools.